WACKER REFOCUS: pursue GDP+ growth, 15% EBITDA margin and ROCE >10%

REFOCUS strategy

WACKER presented REFOCUS to unlock full potential by driving selective growth and sustainably increasing profitability. The approach centres on selective market focus, differentiated portfolio steering and the PACE cost‑savings and efficiency programme, built on three strategic priorities: elevating the business model and value proposition, unleashing the potential of structure and processes, and excelling with people and culture.

Financial ambitions

The Group aims to outpace global economic growth and target an EBITDA margin of 15% (±2 percentage points) with ROCE sustainably above 10%. Key drivers are an improved product mix, accelerated growth in selected segments and cost savings from PACE.

Execution and capital allocation

WACKER will steer investments, innovations and resources to businesses with attractive growth profiles—notably electronics, healthcare and mobility—while prioritising operational excellence and higher ROCE in mature markets. Planned annual investments are €300–€400 million, below depreciation and amortisation.

Business divisions and outlook

Silicones will emphasise e‑mobility and high‑performance electronics solutions; Polymers will double down on VAE dispersions and bespoke solutions; Biosolutions targets biopharma, medical and renewables‑based food ingredients; Polysilicon aims to extend semiconductor‑grade leadership, supported by a new Burghausen production line that went on stream last year. Management expects Q3 EBITDA to be on par with Q2, with chemicals stable to slightly better and polysilicon remaining challenging.

Sustainability

WACKER reconfirms Net Zero by 2045 and reported a 43% reduction in CO2 emissions in 2025 versus the 2020 base year, with focus areas including renewable energy, energy efficiency and biocarbon‑based "green silicon."